| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/23/2012 | WO2012022801A1 Process for preparing a propiolic acid or a derivative thereof |
| 02/23/2012 | WO2012022792A1 2-(arylamino)-3h-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as mpges-1 inhibitors |
| 02/23/2012 | WO2012022707A1 Substituted heteroaryl spiropyrrolidine mdm2 antagonists |
| 02/23/2012 | WO2012022121A1 Fused ring compound for use as mineralocorticoid receptor antagonist |
| 02/23/2012 | WO2011158044A3 Respiratory formulations containing p38 mapk inhibitors |
| 02/23/2012 | US20120046306 Substituted Heteroaryl Spiropyrrolidine MDM2 Antagonists |
| 02/23/2012 | US20120046297 Crystalization of pharmaceutical compounds |
| 02/23/2012 | US20120046283 Compounds for treating neuropsychiatric conditions |
| 02/23/2012 | US20120046282 Methods and compounds for antimicrobial intervention |
| 02/23/2012 | US20120046270 Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases |
| 02/23/2012 | US20120046269 Novel Amino Azaheterocyclic Carboxamides |
| 02/23/2012 | US20120046246 Methods for treating osteoclast-related disease, compounds and compositions thereof |
| 02/23/2012 | US20120045500 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 02/23/2012 | US20120045412 Cycloalkylidene and heterocycloalkylidene inhibitor compounds |
| 02/23/2012 | CA2808678A1 Fused ring compound for use as mineralocorticoid receptor antagonist |
| 02/23/2012 | CA2808624A1 Lipidated immune response modifier compound compositions, formulations, and methods |
| 02/23/2012 | CA2807364A1 Oxadiazole inhibitors of leukotriene production |
| 02/23/2012 | CA2807089A1 2-(arylamino)-3h-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as mpges-1 inhibitors |
| 02/22/2012 | EP2420502A1 Fused pyrrolopyridine derivative |
| 02/22/2012 | EP2420491A1 3 , 5-substitued piperidine compounds as renin inhibitors |
| 02/22/2012 | EP2419428A1 Imidazo [1,2-a]pyridine derivatives as fgfr kinase inhibitors for use in therapy |
| 02/22/2012 | EP2419427A1 Bicyclic heterocyclyl derivatives as fgfr kinase inhibitors for therapeutic use |
| 02/22/2012 | EP2419417A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2 |
| 02/22/2012 | EP2326644B1 Urotensin ii receptor antagonists |
| 02/22/2012 | EP2245028B1 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 02/22/2012 | EP2152709B1 Morphinan compounds |
| 02/22/2012 | EP1995240B1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 02/22/2012 | EP1590328B1 (2-carboxamido) (3-amino) thiophene compounds |
| 02/22/2012 | EP1534680B1 Prenylation inhibitors and methods of their synthesis and use |
| 02/22/2012 | EP1507778B1 Anti-tumour polycyclic carboxamides |
| 02/22/2012 | EP0986384B1 Inhibitors of protein isoprenyl transferases |
| 02/22/2012 | CN102361871A Lyotropic liquid crystal systems based on aromatic tetracarboxylic bisbenzoimidazole derivatives and methods for making |
| 02/22/2012 | CN102361870A Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof |
| 02/22/2012 | CN102361859A Heteroaryl compounds useful as Raf kinase inhibitors |
| 02/22/2012 | CN102358741A Azepinoindole derivatives as pharmaceutical agents |
| 02/22/2012 | CN102358739A Synthetic method for imidazole[1,2-a]pyridine and 2-butyl-5-chloro-1H-imidazole-4-carboxaldehyde compounds |
| 02/21/2012 | US8119804 Organic semiconducting layers |
| 02/21/2012 | US8119802 Fluorinated dyes and their use in electrophoretic display devices |
| 02/21/2012 | US8119658 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| 02/21/2012 | US8119655 Kinase inhibitors |
| 02/21/2012 | US8119635 Diazabicyclic central nervous system active agents |
| 02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme |
| 02/21/2012 | CA2663984C Biaryl ether urea compounds |
| 02/21/2012 | CA2610794C Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
| 02/21/2012 | CA2528784C Hexahydropyridoisoquinolines as dpp-iv inhibitors |
| 02/21/2012 | CA2248800C Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 02/16/2012 | WO2012021444A1 Besylate salt of a btk inhibitor |
| 02/16/2012 | WO2012020821A1 Prophylactic or therapeutic agent for non-alcoholic steatohepatitis |
| 02/16/2012 | WO2012020813A1 Fused-ring pyrrolidine derivative |
| 02/16/2012 | WO2012020762A1 Hetero ring compound |
| 02/16/2012 | WO2012020725A1 Heterocyclic derivative having npy y5 receptor antagonism |
| 02/16/2012 | WO2012020035A1 New azacyclic compounds |
| 02/16/2012 | WO2012020016A1 Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound |
| 02/16/2012 | WO2012019954A1 Pyrazolopyridine compounds as pde10a inhibitors |
| 02/16/2012 | WO2012019430A1 Phthalazinone derivative, and preparation method and pharmaceutical use thereof |
| 02/16/2012 | WO2012019426A1 Phthalazinone derivative, and preparation method and pharmaceutical use thereof |
| 02/16/2012 | WO2011163610A3 Antimicrobial agents |
| 02/16/2012 | WO2010141796A3 PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES |
| 02/16/2012 | US20120041205 Preparation of dihydropyrrol derivatives as intermediates |
| 02/16/2012 | US20120041197 Pyrido[3,2-h]quinazolines and/or 5,6-dihydro Derivatives Thereof, a Method for the Production Thereof and Doped Organic Semiconductor Material Containing These |
| 02/16/2012 | US20120041195 Heterocyclic compounds |
| 02/16/2012 | US20120041017 Pyridocarbazole type compounds and applications thereof |
| 02/16/2012 | US20120041013 New azacyclic compounds |
| 02/16/2012 | US20120041012 Substituted spirocyclic amines useful as antidiabetic compounds |
| 02/16/2012 | US20120041002 Substituted pyrazolo [1,5-a] pyrimidines as metabotropic glutamate antagonists |
| 02/16/2012 | US20120041001 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/16/2012 | US20120041000 Imidazo [1,2-a]pyridine derivatives as fgfr kinase inhibitors for use in therapy |
| 02/16/2012 | US20120040990 Indol-3-y-carbonyl-piperidin and piperazin-derivatives |
| 02/16/2012 | US20120040978 Heterocyclic Fused Cinnoline M1 Receptor Positive Allosteric Modulators |
| 02/16/2012 | US20120040968 Diamino heterocyclic carboxamide compound |
| 02/16/2012 | US20120040966 Anti-viral compounds, treatment, and assay |
| 02/16/2012 | US20120040957 Novel Bicyclic Antibiotics |
| 02/16/2012 | US20120040954 Novel anti-inflammatory agents |
| 02/16/2012 | US20120040951 Heteroaryl compounds useful as raf kinase inhibitors |
| 02/16/2012 | US20120040950 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 02/16/2012 | US20120040942 Novel bronchodilating diazaheteroaryls |
| 02/16/2012 | US20120040936 Cyclic compound having substituted phenyl group |
| 02/16/2012 | US20120040935 Compositions useful as inhibitors of voltage-gated ion channels |
| 02/16/2012 | US20120040020 Compounds useful as inhibitors of atr kinase |
| 02/16/2012 | US20120039849 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase |
| 02/16/2012 | CA2808435A1 Heterocyclic compound |
| 02/16/2012 | CA2808039A1 Prophylactic or therapeutic agent for non-alcoholic steatohepatitis |
| 02/16/2012 | CA2807971A1 Heteroaryls and uses thereof |
| 02/16/2012 | CA2807082A1 Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound |
| 02/16/2012 | CA2806159A1 New azacyclic compounds |
| 02/15/2012 | EP2418211A1 Deuterated morphinane compounds |
| 02/15/2012 | EP2418209A1 Aurora kinase modulators and method of use |
| 02/15/2012 | EP2418203A1 Cyclic compound having substituted phenyl group |
| 02/15/2012 | EP2417973A1 SUSTAINED RELEASE COMPOSITION CONTAINING TETRAHYDROPYRIDO Ý4, 3-b¨INDOLE DERIVATIVE AND PREPARATION METHOD OF DERIVATIVE |
| 02/15/2012 | EP2417136A1 Imidaz0ý1,2-a¨pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture |
| 02/15/2012 | EP2417135A1 Substituted triazolopyridines and analogs thereof |
| 02/15/2012 | EP2417134A1 Macrocyclic serine protease inhibitors |
| 02/15/2012 | EP2417133A1 Compounds and methods for antiviral treatment |
| 02/15/2012 | EP2417132A2 Herbicidal quinoline and 1,8-naphthyridine compounds |
| 02/15/2012 | EP2417127A1 Kinase inhibitors and method of treating cancer with same |
| 02/15/2012 | EP2417112A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof |
| 02/15/2012 | EP2416772A1 Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent |
| 02/15/2012 | EP2124944B1 Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors |
| 02/15/2012 | EP1831199B1 MMP inhibitors |
| 02/15/2012 | EP1771441B8 Novel carboxamides for use as xa inhibitors |